TRILOGY ACET SHELL 36MM O TRILOGY ACET SHELL 38MM O TRILOGY ACET SHELL 40MM O TRILOGY ACET SHELL 42MM O TRILOGY ACET SHELL 44MM O TRILOGY ACET SHELL 46MM O TRILOGY ACET SHELL 48MM O TRILOGY ACET SHELL 50MM O TRILOGY ACET SHELL 52MM O TRILOGY ACET SHELL 54MM O TRILOGY ACET SHELL 56MM O TRILOGY ACET SHELL 58MM O TRILOGY ACET SHELL 60MM O TRILOGY ACET SHELL 62MM O TRILOGY ACET SHELL 64MM O TRILOGY ACET SHELL 66MM O TRILOGY ACET SHELL 68MM O TRILOGY ACET SHELL 70MM O TRILOGY ACET SHELL 72MM O TRILOGY ACET SHELL 74MM O TRILOGY ACET SHELL 76MM O TRILOGY ACET SHELL 78MM O TRILOGY ACET SHELL 80MM O BONE SCREW 4.5X15 SELF-TA BONE SCREW 4.5X20 SELF-TA BONE SCREW 4.5X25 SELF-TA BONE SCREW 4.5X30 SELF-TA BONE SCREW 4.5X35 SELF-TA BONE SCREW 4.5X40 SELF-TA BONE SCREW 4.5X50 SELF-TA BONE SCREW 4.5X60 SELF-TA BONE SCREW 6.5X15 SELF-TA BONE SCREW 6.5X20 SELF-TA BONE SCREW 6.5X25 SELF-TA BONE SCREW 6.5X30 SELF-TA BONE SCREW 6.5X35 SELF-TA BONE SCREW 6.5X40 SELF-TA BONE SCREW 6.5X50 SELF-TA BONE SCREW 6.5X60 SELF-TA BONE SCREW 6.5X70 SELF-TA BONE SCREW 6.5X80 SELF-TA
FDA Recall Z-1024-2014 · Posted 2014-02-20
Advertisement
Recalling FirmZimmer, Inc.
Recall StatusTerminated
Product CodeLPH
Date Initiated2013-10-11
Date Terminated2017-04-14
Product Quantity7,044,680 total
Reason for Recall
Zimmer recently conducted a review of all historic packaging validations at its Zimmer Manufacturing B.V. (ZMBV) facility in Ponce, Puerto Rico. Based on this review, it was determined that the packaging operations conducted in the Building 1 packaging operation at this facility were not properly validated. As a result, Zimmer conducted seal integrity testing to evaluate if previously packaged product from this facility met the established requirements for sterile barrier integrity. The acceptance criteria established for this testing was 99% reliability with a 90% confidence interval. These packaging tray configurations met the acceptance criteria for sterile barrier integrity of both the inner and outer trays, however, Zimmer has decided to recall all manufacturing lots that have not expired and that were sterile packaged in the ZMBV facility Building 1 packaging operations.
Firm Action
Distributors received a letter identifying the issue and their responsibilities dated November 4, 2013. These responsibilities include quarantining the affected fielded inventory in their possession, providing hospital risk managers with the recall notification letter and retrieving affected fielded inventory and direct sales from the hospitals.
Root Cause
Packaging
Distribution Pattern
Worldwide Distribution-USA (nationwide) and the countries of Belgium, Canada, Canary Islands, China, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Italy, Japan, Korea, Luxemburg, Netherlands, New Zealand, Norway, Portugal Reunion, Russian Federation, Singapore, Slovakia, Spain, Sweden, Switzerland, Turkey, Taiwan, Thailand, and United Kingdom.
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement